Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sakano

Showing results (1-10 of 155) with videos related to

Pageof 16
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1981
[Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)]T Sakano
[Kango Gijutsu] : [Nursing Technique]|July 1, 1982
[Therapy of malignant lymphoma and related problems]T Sakano
Japanese Journal of Medicine|February 1, 1984
Present status and problems of treatment of malignant lymphoma in JapanT Sakano
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|October 1, 1974
[Clinical evaluation of new antileukemic agent. 1) Cyclocytidine (author's transl)]T Sakano
Rinsho Hoshasen. Clinical Radiography|January 1, 1979
[Current status of chemotherapy of non-Hodgkin's lymphoma in Japan and Western countries (author's transl)]T Sakano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1978
[Current status and future problems of non-Hodgkin's lymphoma. I. Special reference with staging of non-Hodgkin's lymphoma (author's transl)]T Sakano
Immunology|February 1, 1980
Enhancement of T-cell response to PWM by neuraminidase-treated non-T cellsT Sakano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 3. Progress in therapeutic results. (3). Present status and problems of treatment of malignant lymphoma in Japan]T Sakano
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 1, 1983
[Staging of Hodgkin's disease and choice of treatment]T Sakano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1991
[Chemotherapy of malignant lymphoma, with special regard to non-Hodgkin's lymphomas]T Sakano
Pageof 16

Showing results (1-10 of 155) with videos related to

Sort By:
Pageof 16
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1981
[Present status and future problems in non-Hodgkin's lymphoma. III. On the chemotherapy of non-Hodgkin's lymphoma (author's transl)]T Sakano
[Kango Gijutsu] : [Nursing Technique]|July 1, 1982
[Therapy of malignant lymphoma and related problems]T Sakano
Japanese Journal of Medicine|February 1, 1984
Present status and problems of treatment of malignant lymphoma in JapanT Sakano
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|October 1, 1974
[Clinical evaluation of new antileukemic agent. 1) Cyclocytidine (author's transl)]T Sakano
Rinsho Hoshasen. Clinical Radiography|January 1, 1979
[Current status of chemotherapy of non-Hodgkin's lymphoma in Japan and Western countries (author's transl)]T Sakano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1978
[Current status and future problems of non-Hodgkin's lymphoma. I. Special reference with staging of non-Hodgkin's lymphoma (author's transl)]T Sakano
Immunology|February 1, 1980
Enhancement of T-cell response to PWM by neuraminidase-treated non-T cellsT Sakano
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|October 1, 1983
[Malignant lymphoma--recent progress in diagnosis and treatment. 3. Progress in therapeutic results. (3). Present status and problems of treatment of malignant lymphoma in Japan]T Sakano
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 1, 1983
[Staging of Hodgkin's disease and choice of treatment]T Sakano
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 1, 1991
[Chemotherapy of malignant lymphoma, with special regard to non-Hodgkin's lymphomas]T Sakano
Pageof 16